JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fortney, S. R.
Right arrow Articles by Stein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fortney, S. R.
Right arrow Articles by Stein, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 2, 277-284, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


INHIBITION OF GLUCONEOGENESIS BY HYDRAZINE ADMINISTRATION IN RATS

Sidney R. Fortney 1, Dale A. Clark 1, and Eduardo Stein 1

1 Physiological Chemistry Section, United States Air Force School of Aerospace Medicine, Brooks Air Force Base, Texas

Hydrazine, a known hypoglycemic agent, was studied to determine the mechanisms of its effects on carbohydrate metabolism. Rats previously fasted for 24 hr were injected i.v. with hydrazine, and blood glucose, lactate and pyruvate were measured. As previously described in dogs, hydrazine caused hypoglycemia and elevation of blood lactate and pyruvate in rats. Injection of 1 mmol of alanine, aspartate or pyruvate did not prevent the hypoglycemia. The effect of hydrazine on gluconeogenesis was studied by determining the incorporation of C14 into blood glucose 1 hr after administration of uniformly labeled L-alanine-C14, uniformly labeled L-aspartate-C14 or pyruvate-3-C14. Incorporation was measured in control rats and in rats injected i.v. 5 min previously with hydrazine. In the latter group, C14-incorporation into blood glucose from all three precursors was only approximately 25% of that observed in the control group. When pyruvate-3-C14 was administered, the specific activity of blood pyruvate in the rats injected with hydrazine exceeded the specific activity of blood pyruvate in controls. These findings demonstrate that hydrazine inhibited gluconeogenesis and simultaneously caused hypoglycemia and elevated blood lactate and pyruvate. No incorporation of C14 into glycogen was found in hydrazine-treated animals, probably because of decreased gluconeogenesis and increased glycogenolytic activity.

Submitted on September 13, 1966
Accepted on November 22, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.